Patents
Patents for C07C 391 - Compounds containing selenium (659)
06/2003
06/19/2003WO2003050071A1 Process for the preparation of methionine
06/19/2003CA2469526A1 Process for the preparation of methionine
06/10/2003US6576780 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
05/2003
05/29/2003US20030100583 Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using them
05/27/2003US6569897 Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
05/21/2003CN1419532A Novel fatty acid analogous
05/01/2003US20030083383 Formed by mixing N-(tert-butoxycarbonyl)-L-serine with diethyl azodicarboxylate and triphenylphosphine, forming l-serine-beta-lactone which is mixed with methyl selenol, then deesterifying; anticancer agents
04/2003
04/23/2003CN1106371C Liquid crystal compounds having perfluoroether terminal portions
03/2003
03/19/2003EP1293498A1 Selenium complex with haloethanoic acid or its anhydride, and use thereof in the topical treatment of neoplasms
03/18/2003US6534664 Polymerization catalysts
02/2003
02/26/2003EP1285652A1 Novel fatty acid analogues for the treatment of hypertension
02/20/2003WO2003014073A1 Fatty acid compounds, preparation and uses thereof
02/20/2003CA2456288A1 Fatty acid compounds, preparation and uses thereof
02/19/2003EP1284139A1 Novel fatty acid analogues for the treatment of fatty liver
02/18/2003US6521793 Aromatic secondary amines; polymerization catalysts
02/13/2003WO2003011819A1 Butyric acid derivatives
02/13/2003CA2455749A1 Butyric acid derivatives
01/2003
01/16/2003US20030012803 E.g., ethyl 3-methyl-5-(,5,8,8-tetra-methyl-5,6,7,8-tetra-hydronaphthalen-2 -ylselenyl)pent-2-en-4-ynoate; dermatological, rheumatic, respiratory, cardiovascular and ophthalmological uses as well as cosmetic uses
01/14/2003US6506286 Reactant, compound and process for the perfluoroalkylation of a nucleophile, and the derivatives obtained
12/2002
12/26/2002US20020198259 Treatment of disease caused by procedural vascular trauma and/or an increased level of plasma homocysteine
12/18/2002EP1265838A1 Novel fatty acid analogous
12/17/2002US6495517 Cyclooxygenase inhibitor
11/2002
11/19/2002US6482918 High refractive index, low dispersion and excellent optical property, and is used for a glasses lens, camera lens, prism, substrate for an information recording medium, pick up lens, optical fiber, optical filter
09/2002
09/26/2002WO2002028917A3 Resin and its use in converting morphine to codeine
09/18/2002EP0840604B1 Non-beta-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof
09/18/2002CN1369483A Methyleneseleno propanel method for preparing selenoic methionine
09/03/2002US6444709 Skin disorders; antiinflammatory agents; antiarthritic agents; cardiovascular disorders
08/2002
08/29/2002US20020120097 High refractive index, low dispersion and excellent optical property, and is used for a glasses lens, camera lens, prism, substrate for an information recording medium, pick up lens, optical fiber, optical filter
08/27/2002US6441036 Treating atherosclerosis and insulin resistance
08/27/2002US6441010 Bi-aromatic compounds linked via a heteroethynylene radical, and pharmaceutical and cosmetic compositions containing them
08/21/2002EP1232750A1 Non-beta-oxidizable fatty acid analogues and their use for reduction of growth of cancer cells
08/21/2002EP1232749A1 Non-beta-oxidizable fatty acid analogues and their uses for inhibition of oxidative modification of low density lipoprotein
08/07/2002EP0986537B1 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
08/07/2002EP0638112B1 Liquid crystal compounds having perfluoroether terminal portions
07/2002
07/10/2002EP0952975B1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
07/09/2002US6417232 Fatty acid analogues for the treatment of primary and secondary restenosis
06/2002
06/27/2002US20020082357 Resin comprising a solid support and at least one cationic methylated sulfonium, sulfoxonium, selenonium or phosphonium salt immobilized on the solid support for use as methylating agent
06/13/2002US20020072632 Catalyst ligands, catalytic metal complexes and processes using same
05/2002
05/15/2002EP1205471A1 A method of using synthetic L-SE-Methylselenocysteine as a nutriceutical and a method of its synthesis
04/2002
04/11/2002WO2002028917A2 Resin and its use in converting morphine to codeine
04/10/2002CN1343656A Taurine-metal ion match and its preparing process
04/02/2002US6365628 Fatty analogues for the treatment of diabetes
03/2002
03/28/2002US20020038061 Synthesis of fluorocarbon compounds
03/05/2002CA2126465C Inhibitor for restenosis after percutaneous coronary arterioplasty
02/2002
02/06/2002EP0729354B1 Farnesyl derivatives and pharmaceutical compositions containing them
01/2002
01/23/2002EP1174423A1 Substrates for thioredoxin reductase
12/2001
12/27/2001US20010056105 Useful as cosmetic for hair and body hygiene, and for treatment of dermatological complaints, with an inflammatory and/or immunoallergic component of rheumatic or respiratory type, cardivascular and opthalmogical disorders
11/2001
11/28/2001EP0810993B1 Reagent, compound and method for nucleophile perfluoroalkylation, and resulting derivatives
11/13/2001US6316636 Synthesis of fluorocarbon compounds
10/2001
10/16/2001US6303747 Selenium-containing polythiol having 3 or more functional groups; monomers for preparing transparent optical material which has high refractive index, low dispersion and excellent optical properties
10/04/2001US20010027176 Cyclooxygenase inhibitor
09/2001
09/20/2001WO2001068582A1 Novel fatty acid analogous
09/20/2001WO2001068575A1 Fluoroalkylonium salt type cation or acid generator generating cation or acid upon irradiation with energy ray
08/2001
08/21/2001CA2030792C Perfluorovinyl compounds
07/2001
07/25/2001CN1305458A Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
07/04/2001CN1302204A Novel fatty analogues for treatment of diabetes
06/2001
06/20/2001CN1300212A Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
06/20/2001CN1300211A Novel fatty analogues for the treatment of premary and secondary restenosis
03/2001
03/28/2001EP1086153A1 A solid support based on selenium useful in solid phase synthesis
03/28/2001EP1086080A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
03/27/2001US6207708 For therapy and prophylaxis of autoimmune and/or inflammatory conditions affecting the joints such as arthritis, and inflammatory bowel disease, cardivascular ischemia, diabetes, congestive heart failure, myocarditis, atherosclerosis,
03/20/2001US6203721 For grafting a substituted difluoromethyl group onto a compound containing electrophilic group
03/13/2001US6201019 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
02/2001
02/28/2001EP0792255B1 Liquid crystal compounds having perfluoroether terminal portions
02/14/2001EP1075260A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis
02/14/2001EP1075259A1 Novel fatty analogues for the treatment of diabetes
02/14/2001EP1075258A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
12/2000
12/05/2000US6156163 Reactant, compound and process for the perfluoroalkylation of the nucleophile, and the derivatives obtained
11/2000
11/14/2000CA1341138C Fluorine-containing chiral smectic liquid crystals
11/02/2000EP1047656A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors
10/2000
10/24/2000CA2021547C Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins
10/05/2000WO2000058281A1 Substrates for thioredoxin reductase
10/05/2000CA2368484A1 Substrates for thioredoxin reductase
09/2000
09/27/2000EP1037872A1 Catalyst ligands, catalytic metal complexes and processes using same
09/27/2000EP0885188B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
09/26/2000US6124424 A transparent optical lens is obtained by cast-polymerizing at least one reactive monomer or oligomer having at least one selenium atom in its molecule; improved refractive index
09/13/2000EP0763017B1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors
05/2000
05/30/2000CA1341010C Compounds useful in preparing fluorine-containing chiral smectic liquid crystals
04/2000
04/13/2000WO2000020377A1 Catalyst ligands, catalytic metal complexes and processes using same
04/04/2000US6046237 Non-β-oxidizable fatty acid analogues, their uses as therapeutic active medicaments
03/2000
03/22/2000EP0986537A2 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
03/21/2000US6040328 Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
03/09/2000WO1999058123A3 Novel fatty acid analogues for the treatment of primary and secondary restenosis
02/2000
02/09/2000CN1243749A Inhibitor
01/2000
01/26/2000EP0626943B1 Bistriazenes as chemotherapeutic agents
01/26/2000CN1242764A Compounds useful for perhalogenoalkylation, reagent for implementing these compounds and synthesis method for obtg. same
01/19/2000EP0972515A2 Cyclooxygenase Inhibitor
01/13/2000WO2000001380A1 cyclo-oxygenase inhibitor
01/05/2000EP0751930B1 Amidino derivatives useful as nitric oxide synthase inhibitors
01/05/2000DE19915954A1 Cyclooxygenaseinhibitor Cyclooxygenase
01/01/2000CA2276984A1 Cyclooxygenase inhibitor
12/1999
12/23/1999WO1999065872A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
11/1999
11/24/1999CN1236359A Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same
11/18/1999WO1999058123A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis
11/18/1999WO1999058122A1 Novel fatty analogues for the treatment of diabetes
11/18/1999WO1999058121A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
11/18/1999WO1999058120A1 USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
11/18/1999WO1999050239A3 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
11/09/1999US5981511 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
11/03/1999EP0952975A1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
1 2 3 4 5 6 7